Outcome after surgical treatment of suspected gastrointestinal stromal tumors involving the duodenum: Is limited resection appropriate?

2008 ◽  
Vol 97 (5) ◽  
pp. 388-391 ◽  
Author(s):  
Brian K.P. Goh ◽  
Pierce K.H. Chow ◽  
Sittampalam Kesavan ◽  
Wai-Ming Yap ◽  
Wai-Keong Wong
1998 ◽  
Vol 84 (1) ◽  
pp. 78-81 ◽  
Author(s):  
Carlo Ballarini ◽  
Mattia Intra ◽  
Andrea Pisani Ceretti ◽  
Francesco Prestipino ◽  
Filippo Maria Bianchi ◽  
...  

Gastrointestinal stromal tumors (GIST) constitue the largest category of primary non-epithelial neoplasms of the stomach and small bowel. They are characterized by a remarkable cellular variability and their malignant potential is sometimes difficult to predict. Very recent studies, using mitotic count and tumor size as the best determinants of biological behavior, divide GISTs into three groups: benign, borderline and malignant tumors. We report on a male patient who underwent a right hepatectomy for a large metastasis 11 years after the surgical treatment of an antral-pyloric gastric neoplasm, histologically defined as leiomyoblastoma and with clinical, morphological and immunohistochemical features of benignity (low mitotic count, tumor size < 5 cm, low cellular proliferation index). Histological and immunohistochemical analysis of the hepatic metastasis showed the cellular proliferation index (Ki-67) to be positive in 25% of neoplastic cells, as opposed to the primary gastric tumor in which Ki-67 was positive in only 5% of neoplastic cells. In conclusion, although modern immunohistochemical techniques are now available to obtain useful prognostic information, the malignant potential of GISTs is sometimes difficult to predict: neoplasms clinically and histologically defined as benign could metastasize a long time after oncologically correct surgical treatment. Therefore, benign GISTs also require consistent, long-term follow-up.


2017 ◽  
Vol 2 (6) ◽  
pp. 56-56 ◽  
Author(s):  
Mark Igorevich Gluzman ◽  
Victor Anatolevich Kashchenko ◽  
Aleksei Mikhailovich Karachun ◽  
Rashida Vakhidovna Orlova ◽  
Iakov Aleksandrovich Nakatis ◽  
...  

2021 ◽  
pp. molcanther.0403.2021
Author(s):  
Gustav Johansson ◽  
Marta Berndsen ◽  
Stefan Lindskog ◽  
Tobias Österlund ◽  
Henrik Fagman ◽  
...  

2021 ◽  
Vol 13 (8) ◽  
pp. 959-969
Author(s):  
Yun-Zi Wu ◽  
Yang Li ◽  
Ming Wu ◽  
Xiao-Hao Zheng ◽  
Yan-Tao Tian ◽  
...  

2017 ◽  
Vol 6 (6) ◽  
pp. 38
Author(s):  
A. B. Ryabov ◽  
I. V. Poddubnyi ◽  
V. O. Trunov ◽  
M. Yu. Kozlov ◽  
I. V. Kolobaev ◽  
...  

2018 ◽  
Vol 36 (3) ◽  
pp. 206-217 ◽  
Author(s):  
Shuisheng Zhang ◽  
Yuan Tian ◽  
Yingtai Chen ◽  
Jianwei Zhang ◽  
Cuiling Zheng ◽  
...  

Background: Duodenal gastrointestinal stromal tumors (GISTs) are rare and their clinicopathological features have not been completely described. In this retrospective study, we examined the characteristics and long-term outcomes of patients who underwent surgical treatment for duodenal GISTs. Methods: We examined patients surgically treated for duodenal GISTs from 1999 to 2016 at the China National Cancer Center. We analyzed patient characteristics, treatments, histological examinations, and survival outcomes. Results: The 52 surgeries performed included 14 pancreaticoduodenectomies (26.9%), 37 limited resections (71.2%), and one palliative bypass procedure (1.9%). No surgery-related death occurred. The complication rate in patients who underwent pancreaticoduodenectomy was slightly higher than that in patients who underwent limited resection. The 5-year overall survival and progression-free survival rates for patients with duodenal adenocarcinoma were 89.1 and 72.9%, respectively. The overall survival and progression-free survival rates were not significantly related to surgical methods. Large tumor size and high mitotic rate were associated with poor overall survival outcomes. However, no independent factor was associated with prognosis, which may be due to the small sample size. Conclusion: The prognosis of duodenal gastrointestinal stromal tumors was good. Limited resection seems to be oncologically feasible, with outcomes being less worse than those of pancreaticoduodenectomy.


2018 ◽  
Vol 3 ◽  
pp. 71-71 ◽  
Author(s):  
Georgi Popivanov ◽  
Mihail Tabakov ◽  
George Mantese ◽  
Roberto Cirocchi ◽  
Irene Piccinini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document